Search Results
Search for other papers by R. H. McCusker in
Google Scholar
PubMed
Search for other papers by D. R. Campion in
Google Scholar
PubMed
ABSTRACT
Tumours secreting GH (GH1) or GH plus prolactin (GH3) were induced in young (1-week-old) and mature (17-week-old) female Wistar–Furth rats. Young animals were killed at 11 weeks and mature rats at 30 weeks of age. Induction of tumours increased serum GH concentrations and body and soleus muscle weights when compared with those of control rats. The soleus and extensor digitorum longus (EDL) muscles were examined in transverse section by electron microscopy. The percentages of myofibres with myonuclei and with satellite cell nuclei present in both the soleus and EDL muscles were generally greater in young rats with tumours than in young control rats. The percentage of myofibres in the EDL muscle with myonuclei present was higher in mature rats with GH1 tumours compared with age-matched controls. The presence of tumours did not affect the number of fibres in the soleus muscle of either young or mature rats. It was concluded that increased GH concentrations increased muscle weight by increasing the DNA content of myofibres and by myofibre hypertrophy. The rate of proliferation of satellite cells apparently exceeded the rate of incorporation of daughter nuclei into the fibres of the young tumourbearing rats when compared with that of young controls. Thus, the factors regulating satellite cell proliferation and nuclear incorporation into the myofibre do not appear to be directly coupled.
J. Endocr. (1986) 111, 279–285
Search for other papers by Alexander Hennebry in
Google Scholar
PubMed
Search for other papers by Jenny Oldham in
Google Scholar
PubMed
Search for other papers by Tea Shavlakadze in
Google Scholar
PubMed
Search for other papers by Miranda D Grounds in
Google Scholar
PubMed
Search for other papers by Philip Sheard in
Google Scholar
PubMed
Search for other papers by Marta L Fiorotto in
Google Scholar
PubMed
Search for other papers by Shelley Falconer in
Google Scholar
PubMed
Search for other papers by Heather K Smith in
Google Scholar
PubMed
Search for other papers by Carole Berry in
Google Scholar
PubMed
Search for other papers by Ferenc Jeanplong in
Google Scholar
PubMed
Search for other papers by Jeremy Bracegirdle in
Google Scholar
PubMed
Search for other papers by Kenneth Matthews in
Google Scholar
PubMed
Search for other papers by Gina Nicholas in
Google Scholar
PubMed
Search for other papers by Mônica Senna-Salerno in
Google Scholar
PubMed
Search for other papers by Trevor Watson in
Google Scholar
PubMed
Search for other papers by Christopher D McMahon in
Google Scholar
PubMed
myofibres ( Lee & McPherron 2001 ). However, when myostatin activity is blocked, hypertrophy still requires the presence of IGF1 receptors ( Kalista et al. 2012 , Winbanks et al. 2012 ). Therefore, it appears that IGF1 is critical for enabling the
Search for other papers by Ryan Paul in
Google Scholar
PubMed
Search for other papers by Kim Whiteman in
Google Scholar
PubMed
Search for other papers by Shelley J Falconer in
Google Scholar
PubMed
Search for other papers by Jenny M Oldham in
Google Scholar
PubMed
Search for other papers by Ferenc Jeanplong in
Google Scholar
PubMed
Search for other papers by Kenneth G Matthews in
Google Scholar
PubMed
Search for other papers by Heather K Smith in
Google Scholar
PubMed
Search for other papers by Mark Thomas in
Google Scholar
PubMed
Search for other papers by Trevor Watson in
Google Scholar
PubMed
AgResearch Ltd, Hamilton, New Zealand
Search for other papers by Christopher D McMahon in
Google Scholar
PubMed
-natal life ( Beilharz et al. 1992 ). This is consistent with IGF1 acting to increase hypertrophy of muscle fibres rather than regulating hyperplasia. In contrast, reduced abundance, or absence of myostatin increases hyperplasia of myofibres ( Hennebry et
Search for other papers by Eileen I Chang in
Google Scholar
PubMed
Search for other papers by Paul J Rozance in
Google Scholar
PubMed
Search for other papers by Stephanie R Wesolowski in
Google Scholar
PubMed
Search for other papers by Leanna M Nguyen in
Google Scholar
PubMed
Search for other papers by Steven C Shaw in
Google Scholar
PubMed
Search for other papers by Robert A Sclafani in
Google Scholar
PubMed
Search for other papers by Kristen K Bjorkman in
Google Scholar
PubMed
Search for other papers by Angela K Peter in
Google Scholar
PubMed
Search for other papers by William W Hay Jr in
Google Scholar
PubMed
Search for other papers by Laura D Brown in
Google Scholar
PubMed
proliferation, differentiation, and fusion of satellite cells is an essential regulator of muscle fiber growth by hypertrophy ( White et al. 2010 , Blaauw & Reggiani 2014 , Egner et al. 2016 , Snijders et al. 2016 , Dungan et al. 2019 ); thus
Search for other papers by A M Solomon in
Google Scholar
PubMed
Search for other papers by P M G Bouloux in
Google Scholar
PubMed
Metabolism 88 2784 –2793. Armand AS , Lecolle S, Launay T, Pariset C, Fiore F, Della GB, Birnbaum D, Chanoine C & Charbonnier F 2004 IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice
Search for other papers by Manon M Roustit in
Google Scholar
PubMed
Search for other papers by Joan M Vaughan in
Google Scholar
PubMed
Search for other papers by Pauline M Jamieson in
Google Scholar
PubMed
Search for other papers by Mark E Cleasby in
Google Scholar
PubMed
treatments available. However, recent work has demonstrated that generalised overexpression of urocortin 3 (UCN3) in mice results in both hypertrophy and increased glucose disposal into muscle ( Jamieson et al . 2011 ), making this an interesting candidate
Search for other papers by Laura D Brown in
Google Scholar
PubMed
results in the withdrawal of myoblasts from the cell cycle and subsequent fusion into myotubes. Myotube maturation and hypertrophy are stimulated by growth factors, amino acids, and stretch/load activity ( Molkentin & Olson 1996 , Yang & Makita 1996
Search for other papers by M Granado in
Google Scholar
PubMed
Search for other papers by A I Martín in
Google Scholar
PubMed
Search for other papers by T Priego in
Google Scholar
PubMed
Search for other papers by A López-Calderón in
Google Scholar
PubMed
Search for other papers by M A Villanúa in
Google Scholar
PubMed
mass by enhancing myofibre hypertrophy and stimulating myogenesis ( Musaro et al. 2001 ). However, it has been reported ( Foulstone et al. 2001 ) that the effects of IGF-I on muscle may depend on the cytokine environment in such a way that in the
Search for other papers by Sonnet S Jonker in
Google Scholar
PubMed
Search for other papers by Daniel Kamna in
Google Scholar
PubMed
Search for other papers by Dan LoTurco in
Google Scholar
PubMed
Search for other papers by Jenai Kailey in
Google Scholar
PubMed
Search for other papers by Laura D Brown in
Google Scholar
PubMed
repression in the heart. How cortisol interacts with low levels of IGF1 to suppress growth or induce apoptosis in IUGR skeletal and cardiac muscle remains to be determined. Norepinephrine is a non-selective adrenergic agonist linked to hypertrophy in adult
Search for other papers by Susan M Soto in
Google Scholar
PubMed
Search for other papers by Amy C Blake in
Google Scholar
PubMed
Search for other papers by Stephanie R Wesolowski in
Google Scholar
PubMed
Search for other papers by Paul J Rozance in
Google Scholar
PubMed
Search for other papers by Kristen B Barthel in
Google Scholar
PubMed
Search for other papers by Bifeng Gao in
Google Scholar
PubMed
Search for other papers by Byron Hetrick in
Google Scholar
PubMed
Search for other papers by Carrie E McCurdy in
Google Scholar
PubMed
Search for other papers by Natalia G Garza in
Google Scholar
PubMed
Search for other papers by William W Hay Jr in
Google Scholar
PubMed
Search for other papers by Leslie A Leinwand in
Google Scholar
PubMed
Search for other papers by Jacob E Friedman in
Google Scholar
PubMed
Search for other papers by Laura D Brown in
Google Scholar
PubMed
postnatal muscle growth occurs primarily by hypertrophy ( Rowe & Goldspink 1969 , Wigmore & Stickland 1983 , Fahey et al . 2005 b ). Myogenesis is regulated in part by the fetal growth factors, particularly insulin and insulin-like growth factors (IGFs